Suchergebnisse - (Subject:"*Pneumonia, Viral")

PubPharm (734)

111

Initial CT Findings and CO-RADS Stage in COVID-19 : Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients With PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives

enthalten in: ClinicalTrials.gov | 2021

112

A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19). : A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical trial of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia), in patients with coronavirus disease (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

113

Protective ventilation and outcomes of critically ill patients with COVID-19 : a cohort study

enthalten in: Annals of intensive care | 2021

von Ferreira, J. | Ho, Y. | Besen, B. | +89

114

Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study

enthalten in: Annals of intensive care | 2021

von Ferreira, J. | Ho, Y. | Besen, B. | +10

115

Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study

enthalten in: Annals of intensive care | 2021

von Ferreira, J. | Ho, Y. | Besen, B. | +10

116

A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19). : A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical trial of the safety and efficacy of 12 mg Polyoxidonium®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia), in patients with coronavirus disease (COVID-19)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

117

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 : Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Adjuvant Therapy to Standard Therapy in Patients With and Without Septic Shock Secondary to COVID-19 Severe Pneumonia

enthalten in: ClinicalTrials.gov | 2021

118

A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with a lung disease caused by coronavirus infectionACOVACT (Austrian CoronaVirus Adaptive Clinical Trial) : A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with COVID-19 (caused by infection with severe acute respiratory syndrome coronavirus-2)ACOVACT (Austrian CoronaVirus Adaptive Clinical Trial)

enthalten in: WHO International Clinical Trials Registry Platform | 2021

119

CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS : CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS SARS-CoV-2 (COVID-19): THE HOPE OPEN-LABEL, NON-RANDOMIZED CLINICAL TRIAL - HOPE

enthalten in: WHO International Clinical Trials Registry Platform | 2021

120

A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with a lung disease caused by coronavirus infectionACOVACT (Austrian CoronaVirus Adaptive Clinical Trial) : A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with COVID-19 (caused by infection with severe acute respiratory syndrome coronavirus-2)ACOVACT (Austrian CoronaVirus Adaptive Clinical Trial)

enthalten in: WHO International Clinical Trials Registry Platform | 2021